Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LifeStance Health (LFST) Current Leases: 2022-2024

Historic Current Leases for LifeStance Health (LFST) over the last 3 years, with FY2024 value amounting to $49.4 million.

  • LifeStance Health's Current Leases fell 323.13% to $47.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $47.4 million, marking a year-over-year decrease of 323.13%. This contributed to the annual value of $49.4 million for FY2024, which is 639.91% up from last year.
  • Latest data reveals that LifeStance Health reported Current Leases of $49.4 million as of FY2024, which was up 639.91% from $46.5 million recorded in FY2023.
  • In the past 5 years, LifeStance Health's Current Leases registered a high of $49.4 million during FY2024, and its lowest value of $38.8 million during FY2022.
  • Moreover, its 3-year median value for Current Leases was $46.5 million (2023), whereas its average is $44.9 million.
  • As far as peak fluctuations go, LifeStance Health's Current Leases skyrocketed by 1970.69% in 2023, and later surged by 639.91% in 2024.
  • LifeStance Health's Current Leases (Annual) stood at $38.8 million in 2022, then grew by 19.71% to $46.5 million in 2023, then grew by 6.4% to $49.4 million in 2024.
  • Its Current Leases stands at $49.4 million for FY2024, versus $46.5 million for FY2023 and $38.8 million for FY2022.